CAS dismisses 47 appeals from Russian athletes, coaches

FAN Editor
The CAS is pictured before an appeal hearing of Jamaican sprinter Nesta Carter in Lausanne
FILE PHOTO – The Court of Arbitration for Sports (CAS) is pictured in Lausanne, Switzerland November 15, 2017. REUTERS/Denis Balibouse

February 9, 2018

By Karolos Grohmann

PYEONGCHANG, South Korea (Reuters) – The Court of Arbitration for Sport (CAS) said on Friday it has dismissed 47 appeals from Russian athletes and coaches to participate in the Pyeongchang Winter Olympics, which open later in the day.

The Russians had appealed their exclusion from the Games by the International Olympic Committee (IOC) over the doping scandal from the 2014 Sochi Games.

“In its decisions, the CAS arbitrators have considered that the process created by the IOC to establish an invitation list of Russian athletes to compete as Olympic athletes from Russia (OAR) could not be described as a sanction but rather as an eligibility decision,” it said in a statement.

The IOC in December banned Russia from the Games over doping in the country that included massive manipulation of doping samples at the Sochi Olympics and more than 1,000 athletes across several sports.

It invited 169 carefully screened Russian athletes to compete as neutrals under the Olympic flag. It has also suspended the Russian Olympic Committee (ROC).

“Although the ROC was suspended, the IOC nevertheless chose to offer individual athletes the opportunity to participate in the winter Games under prescribed conditions – a process that was designed to balance the IOC’s interest in the global fight against doping and the interests of individual athletes from Russia.”

The Games begin later on Friday and run to Feb. 25.

(Editing by Peter Rutherford/Greg Stutchbury)

Free America Network Articles

Leave a Reply

Next Post

Trump aims to reduce drug costs under Medicare

WASHINGTON –  President Donald Trump will propose lowering prescription drug costs for Medicare beneficiaries by allowing them to share in rebates that drug companies pay to insurers and middlemen, an administration official said Thursday. Continue Reading Below A senior administration official outlined the plan on condition of anonymity ahead of […]

You May Like